BF Bisciences a subsidiary Of Ferozsons Group

BF Biosciences, a subsidiary of the Ferozsons Group, is a biotechnology company based in the United States. With 70 employees, BF Biosciences specializes in the manufacturing of Hepatitis treatments and other pharmaceutical products. The company generates approximately $50 million in annual revenue. BF Biosciences' core focus lies in providing high-quality pharmaceutical solutions, particularly in the realm of Hepatitis treatment. They prioritize excellence and utilize the technical expertise of BAGO group of Argentina to ensure the highest standards of cGMP (Current Good Manufacturing Practices) throughout their manufacturing processes. The company distinguishes itself through its commitment to producing world-class pharmaceutical products while upholding rigorous manufacturing standards. BF Biosciences' dedication to cGMP ensures that their products meet the highest quality benchmarks, providing patients with safe and effective treatments. For more information about BF Biosciences and their products, please visit their website at bfbio.com.